Targeting eIF4A using rocaglate CR‑1‑31B sensitizes gallbladder cancer cells to TRAIL‑mediated apoptosis through the translational downregulation of c‑FLIP.

Oncol Rep · 2021 · PMC7709814 · PMID 33416145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Tumor weights after 4 weeks of treatment showed a decreasing trend from control, to TRAIL to CR-31 to combination treatment ( Fig. 5A and C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.